TANG CAPITAL MANAGEMENT LLC
Related Filers (25)
- TANG CAPITAL PARTNERS LP (205)
- TANG KEVIN C (202)
- Odonate Therapeutics, Inc. (31)
- Ardea Biosciences, Inc./DE (29)
- Lemkey John G (29)
- LA JOLLA PHARMACEUTICAL CO (28)
- HERON THERAPEUTICS, INC. /DE/ (24)
- Hearne Michael S (21)
- Vanda Pharmaceuticals Inc. (16)
- Northstar Neuroscience, Inc. (15)
- NEOSE TECHNOLOGIES INC (12)
- PENWEST PHARMACEUTICALS CO (11)
- ARADIGM CORP (6)
- TCR2 THERAPEUTICS INC. (6)
- Rain Oncology Inc. (5)
- TAPESTRY PHARMACEUTICALS, INC (4)
- THRESHOLD PHARMACEUTICALS INC (4)
- Aptevo Therapeutics Inc. (4)
- Mirati Therapeutics, Inc. (3)
- Jounce Therapeutics, Inc. (3)
- Cyclacel Pharmaceuticals, Inc. (2)
- ACLARA BIOSCIENCES INC (1)
- DEPOMED INC (1)
- Inspirato Inc (1)
- ASLAN Pharmaceuticals Ltd (1)
- Show More ...
Other (49)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 1/27/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/15/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 4/20/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (207)
4
Wednesday, 2/14/2024
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Friday, 2/2/2024
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/13/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/1/2023
Rain Oncology Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/1/2023
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/30/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Monday, 5/15/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/5/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
3
Friday, 5/5/2023
TCR2 THERAPEUTICS INC.: Initial statement of beneficial ownership of securities
4
Friday, 5/5/2023
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/14/2023
Jounce Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/14/2023
Jounce Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/24/2022
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 4/21/2022
Inspirato Inc: Major Shareholders
SC 13G
Thursday, 4/21/2022
ASLAN Pharmaceuticals Ltd: Major Shareholders
4
Wednesday, 12/1/2021
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 11/26/2021
Aptevo Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/22/2021
Aptevo Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/19/2021
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/1/2021
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/26/2021
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/23/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/6/2020
Aptevo Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Friday, 11/6/2020
Aptevo Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/30/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/9/2020
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/1/2020
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/14/2020
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Thursday, 6/4/2020
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 2/3/2020
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 1/13/2020
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 6/28/2019
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/18/2019
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/10/2019
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/5/2019
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/11/2019
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
5
Thursday, 2/14/2019
LA JOLLA PHARMACEUTICAL CO: Annual statement of changes in beneficial ownership of securities
4
Wednesday, 1/9/2019
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 12/31/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/26/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/18/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/13/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/10/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/29/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/26/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/5/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/30/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/25/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/1/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/26/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/20/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/12/2018
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Thursday, 8/23/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/20/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/15/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/2/2018
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Monday, 3/19/2018
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 3/2/2018
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 3/2/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/27/2018
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/27/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/22/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/16/2018
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/8/2017
Odonate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/6/2017
Odonate Therapeutics, LLC: Initial statement of beneficial ownership of securities
4
Monday, 3/27/2017
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 3/6/2017
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2017
Cyclacel Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 2/27/2017
Cyclacel Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 1/23/2017
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/13/2016
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 6/20/2016
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2016
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2016
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 9/14/2015
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 8/21/2015
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/30/2015
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/24/2015
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 6/12/2015
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/2/2015
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/13/2015
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Thursday, 12/18/2014
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Monday, 12/15/2014
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
4
Friday, 9/26/2014
LA JOLLA PHARMACEUTICAL CO: Statement of changes in beneficial ownership of securities
3
Monday, 8/4/2014
LA JOLLA PHARMACEUTICAL CO: Initial statement of beneficial ownership of securities
4
Friday, 6/27/2014
HERON THERAPEUTICS, INC. /DE/: Statement of changes in beneficial ownership of securities
4
Friday, 11/22/2013
AP PHARMA INC /DE/: Statement of changes in beneficial ownership of securities
4
Monday, 10/28/2013
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/23/2013
Mirati Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 7/15/2013
Mirati Therapeutics, Inc.: Initial statement of beneficial ownership of securities
5
Thursday, 2/14/2013
AP PHARMA INC /DE/: Annual statement of changes in beneficial ownership of securities
4
Friday, 7/27/2012
AP PHARMA INC /DE/: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/9/2012
AP PHARMA INC /DE/: Statement of changes in beneficial ownership of securities
4
Friday, 2/3/2012
Ardea Biosciences, Inc./DE: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2011
AP PHARMA INC /DE/: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/26/2011
AP PHARMA INC /DE/: Statement of changes in beneficial ownership of securities
4
Monday, 1/24/2011
Ardea Biosciences, Inc./DE: Statement of changes in beneficial ownership of securities
5
Monday, 1/24/2011
Ardea Biosciences, Inc./DE: Annual statement of changes in beneficial ownership of securities